These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 33136745

  • 1. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L, Morar N, Kapiga S, Ramjee G, Hayes R.
    J Acquir Immune Defic Syndr; 2020 Dec 01; 85(4):458-465. PubMed ID: 33136745
    [Abstract] [Full Text] [Related]

  • 2. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L.
    AIDS Behav; 2015 May 01; 19(5):784-93. PubMed ID: 25416076
    [Abstract] [Full Text] [Related]

  • 3. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.
    J Int AIDS Soc; 2015 May 01; 18(1):20536. PubMed ID: 26700845
    [Abstract] [Full Text] [Related]

  • 4. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
    Pleasants E, Tauya T, Reddy K, Mirembe BG, Woeber K, Palanee-Phillips T, Zimba C, Atujuna M, Montgomery ET, MTN-020/ASPIRE Study Team.
    AIDS Behav; 2020 Mar 01; 24(3):866-880. PubMed ID: 31111297
    [Abstract] [Full Text] [Related]

  • 5. Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials.
    Miller L, Morar N, Kapiga S, Ramjee G, Hayes R.
    PLoS One; 2021 Mar 01; 16(1):e0244652. PubMed ID: 33411782
    [Abstract] [Full Text] [Related]

  • 6. Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention.
    Miller L, Prieto Merino D, Baisley K, Hayes R.
    PLoS One; 2022 Mar 01; 17(5):e0267011. PubMed ID: 35551324
    [Abstract] [Full Text] [Related]

  • 7. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
    Kelly CA, Friedland BA, Morar NS, Katzen LL, Ramjee G, Mokgatle MM, Ahmed K.
    Cult Health Sex; 2015 Mar 01; 17(8):1004-20. PubMed ID: 25913101
    [Abstract] [Full Text] [Related]

  • 8. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M, Wilcher R, Montgomery ET, Pool R, Schuler S, Lenzi R, Friedland B.
    J Int AIDS Soc; 2014 Mar 01; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [Abstract] [Full Text] [Related]

  • 9. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
    Venables E, Stadler J.
    Cult Health Sex; 2012 Mar 01; 14(2):181-94. PubMed ID: 22085043
    [Abstract] [Full Text] [Related]

  • 10. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M, Palanee-Phillips T, O'Rourke S, Adewumi K, Tenza S, Mathebula F, Wagner D, Ayub A, Montgomery ET.
    AIDS Care; 2019 Jun 01; 31(6):660-666. PubMed ID: 30309246
    [Abstract] [Full Text] [Related]

  • 11. Educating men about vaginal microbicides: considerations from Kenya.
    Gitome SW, Kwena ZA, Harper CC, Cohen CR, Bukusi EA.
    Cult Health Sex; 2020 Jun 01; 22(6):660-674. PubMed ID: 31241426
    [Abstract] [Full Text] [Related]

  • 12. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
    Hoffman S, Morrow KM, Mantell JE, Rosen RK, Carballo-Diéguez A, Gai F.
    Arch Sex Behav; 2010 Jun 01; 39(3):748-60. PubMed ID: 19636696
    [Abstract] [Full Text] [Related]

  • 13. Young Women's use of a microbicide surrogate: the complex influence of relationship characteristics and perceived male partners' evaluations.
    Tanner AE, Fortenberry JD, Zimet GD, Reece M, Graham CA, Murray M.
    Arch Sex Behav; 2010 Jun 01; 39(3):735-47. PubMed ID: 19224355
    [Abstract] [Full Text] [Related]

  • 14. Women and ARV-based HIV prevention - challenges and opportunities.
    Geary CW, Bukusi EA.
    J Int AIDS Soc; 2014 Jun 01; 17(3 Suppl 2):19356. PubMed ID: 25224621
    [Abstract] [Full Text] [Related]

  • 15. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
    Montgomery CM, Lees S, Stadler J, Morar NS, Ssali A, Mwanza B, Mntambo M, Phillip J, Watts C, Pool R.
    AIDS Care; 2008 Jul 01; 20(6):733-40. PubMed ID: 18576176
    [Abstract] [Full Text] [Related]

  • 16. Effects of partnership change on microbicide gel adherence in a clinical trial (HPTN 035).
    Gorbach PM, Kelly CW, Borgerding JA, Ramjee G, Tembo T, Kumwenda N, Musara P, Roberts S, Maslankowski L.
    AIDS Behav; 2014 May 01; 18(5):855-61. PubMed ID: 24158488
    [Abstract] [Full Text] [Related]

  • 17. Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention.
    Hartmann M, Lanham M, Palanee-Phillips T, Mathebula F, Tolley EE, Peacock D, Pascoe L, Zissette S, Roberts ST, Wagner D, Wilson E, Ayub A, Wilcher R, Montgomery ET, CHARISMA team.
    AIDS Educ Prev; 2019 Oct 01; 31(5):433-451. PubMed ID: 31550193
    [Abstract] [Full Text] [Related]

  • 18. Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.
    Succop SM, MacQueen KM, van Loggerenberg F, Majola N, Karim QA, Karim SS.
    AIDS Care; 2014 Oct 01; 26(12):1521-5. PubMed ID: 25285564
    [Abstract] [Full Text] [Related]

  • 19. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.
    BMC Res Notes; 2012 Nov 01; 5():613. PubMed ID: 23116431
    [Abstract] [Full Text] [Related]

  • 20. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET, VOICE-C Study Team.
    J Int AIDS Soc; 2014 Nov 01; 17(3 Suppl 2):19146. PubMed ID: 25224610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.